Bio Green Med Solution (BGMS)
NASDAQ:BGMS
Want to see BGMS full AI Analyst Report?
BGMS Stock Chart & Stats
$1.45
--
Market closed
$1.45
--
Day’s Range― - ―
52-Week Range$0.73 - $19.87
Previous CloseN/A
VolumeN/A
Average Volume (3M)473.94K
Market Cap
$4.18M
Enterprise Value-$1.55M
Total Cash (Recent Filing)$3.34M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.49
Next Earnings
Aug 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield10.27%
Share Statistics
EPS (TTM)-4.40
Shares Outstanding5,519,456
10 Day Avg. Volume1,252,948
30 Day Avg. Volume473,939
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.47
Price to Sales (P/S)4.33
P/FCF Ratio-0.68
Enterprise Value/Market Cap-0.37
Enterprise Value/Revenue-1.02
Enterprise Value/Gross Profit-5.55
Enterprise Value/Ebitda0.43
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-268.8
Revenue Forecast (FY)$100.00K
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthSustained triple-digit TTM revenue growth signals improving commercial traction and market acceptance of the firm's fire-safety and distribution offerings. Over 2–6 months this momentum supports scaling opportunities, better unit economics as volumes rise and a clearer path to leveraging fixed costs.
Low Leverage / Improved CapitalizationA debt-free balance sheet and positive equity provide structural financial flexibility, lowering solvency risk and enabling strategic investments or acquisitions without near-term debt obligation pressure. This supports capital allocation choices while losses are being closed.
Strategic Acquisition Diversifies BusinessThe planned all-stock Future NRG acquisition is a structural strategic pivot into regulated waste-to-energy and bundled compliance services, potentially creating recurring, regulation-driven revenue streams and deeper customer ties across environmental and safety verticals if integration executes.
Bears Say
Deep Operating LossesVery large negative operating and net margins reflect a cost base far exceeding current revenues, implying the company must materially widen margins or scale revenue to reach breakeven. Persistent losses constrain reinvestment, increase funding dependency and slow attainment of sustainable profitability.
Reliance On Equity FinancingRecent offshore private placement underscores dependence on equity to fund operations. Reliance on dilutive financing increases long-term shareholder dilution risk and signals recurring funding needs until cash flow turns positive, limiting financial predictability and strategic optionality.
Small Revenue Base & Low Gross MarginDespite rapid growth, a modest revenue base and low gross margin mean fixed and operating costs remain large relative to sales. Structural scale is required to absorb SG&A and R&D, so profitability improvements depend on sustained revenue expansion and margin enhancement over multiple quarters.
Bio Green Med Solution News
BGMS FAQ
What was Bio Green Med Solution’s price range in the past 12 months?
Bio Green Med Solution lowest stock price was $0.73 and its highest was $19.87 in the past 12 months.
What is Bio Green Med Solution’s market cap?
Bio Green Med Solution’s market cap is $4.18M.
When is Bio Green Med Solution’s upcoming earnings report date?
Bio Green Med Solution’s upcoming earnings report date is Aug 12, 2026 which is in 52 days.
How were Bio Green Med Solution’s earnings last quarter?
Bio Green Med Solution released its earnings results on May 14, 2026. The company reported -$0.04 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.04.
Is Bio Green Med Solution overvalued?
According to Wall Street analysts Bio Green Med Solution’s price is currently Overvalued.
Does Bio Green Med Solution pay dividends?
Bio Green Med Solution pays a Notavailable dividend of $0.15 which represents an annual dividend yield of 10.27%. See more information on Bio Green Med Solution dividends here
What is Bio Green Med Solution’s EPS estimate?
Bio Green Med Solution’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bio Green Med Solution have?
Bio Green Med Solution has 5,519,456 shares outstanding.
What happened to Bio Green Med Solution’s price movement after its last earnings report?
Bio Green Med Solution reported an EPS of -$0.04 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.143%.
Which hedge fund is a major shareholder of Bio Green Med Solution?
Currently, no hedge funds are holding shares in BGMS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bio Green Med Solution
Bio Green Med Solution, Inc. (BGMS) operates as a multifaceted company, with active involvement in both the fire protection and biopharmaceutical industries. The organization recently broadened its capabilities by completing the acquisition of Fitters Sdn. Bhd., a Malaysian firm known for its fire safety products and services. BGMS is committed to driving progress in biopharmaceutical research and developing cutting-edge fire safety solutions, striving to deliver enduring value to its investors.
Technical Analysis
Biodexa Pharmaceuticals
―
―
Rein Therapeutics
―
Bluejay Diagnostics
―
Neuphoria Therapeutics
―
Ownership Overview
57.05% Insiders
0.03% Mutual Funds
<0.01% Other Institutional Investors
42.92% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---